p.85 抽出テキスト

57. Stergiou GS, Palatini P, Parati G, O’Brien E, Januszewicz A, Lurbe E, et al. European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens 2021;39:1293–302. https://doi.org/10.1097/hjh. 0000000000002843 58. Parati G, Stergiou GS, Bilo G, Kollias A, Pengo M, Ochoa J, et al. Home blood pressure monitoring: methodology, clinical relevance and practical application: a 2021 position paper by the working group on blood pressure monitoring and cardiovascular variability of the European Society of Hypertension. J Hypertens 2021;39:1742–67. https://doi. org/10.1097/hjh.0000000000002922 59. Bradley CK, Choi E, Abdalla M, Mizuno H, Lam M, Cepeda M, et al. Use of different blood pressure thresholds to reduce the number of home blood pressure monitoring days needed for detecting hypertension. Hypertension 2023;80:2169–77. https://doi. org/10.1161/hypertensionaha.123.21118 60. Hodgkinson JA, Lee MM, Milner S, Bradburn P, Stevens R, Hobbs FDR, et al. Accuracy of blood-pressure monitors owned by patients with hypertension (ACCU-RATE study): a cross-sectional, observational study in central England. Br J Gen Pract 2020; 70:e548–54. https://doi.org/10.3399/bjgp20X710381 61. Niiranen TJ, Asayama K, Thijs L, Johansson JK, Ohkubo T, Kikuya M, et al. Outcome-driven thresholds for home blood pressure measurement: international database of home blood pressure in relation to cardiovascular outcome. Hypertension 2013;61:27–34. https://doi.org/10.1161/hypertensionaha.111.00100 62. Parati G, Stergiou G, O’Brien E, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 2014;32:1359–66. https://doi.org/10.1097/hjh.0000000000000221 63. Yang WY, Thijs L, Zhang ZY, Asayama K, Boggia J, Hansen TW, et al. Evidence-based proposal for the number of ambulatory readings required for assessing blood pressure level in research settings: an analysis of the IDACO database. Blood Press 2018;27: 341–50. https://doi.org/10.1080/08037051.2018.1476057 64. Asayama K, Stolarz-Skrzypek K, Yang WY, Hansen TW, Brguljan-Hitij J, Odili AN, et al. What did we learn from the international databases on ambulatory and home blood pressure in relation to cardiovascular outcome? Hypertens Res 2023;46:934–49. https://doi.org/10.1038/s41440-023-01191-4 65. Drawz PE, Agarwal A, Dwyer JP, Horwitz E, Lash J, Lenoir K, et al. Concordance between blood pressure in the systolic blood pressure intervention trial and in routine clinical practice. JAMA Intern Med 2020;180:1655–63. https://doi.org/10.1001/ jamainternmed.2020.5028 66. Jaeger BC, Bress AP, Bundy JD, Cheung AK, Cushman WC, Drawz PE, et al. Longer-term all-cause and cardiovascular mortality with intensive blood pressure control: a secondary analysis of a randomized clinical trial. JAMA Cardiol 2022;7:1138–46. https://doi.org/10.1001/jamacardio.2022.3345 67. Ntineri A, Niiranen TJ, McManus RJ, Lindroos A, Jula A, Schwartz C, et al. Ambulatory versus home blood pressure monitoring: frequency and determinants of blood pressure difference and diagnostic disagreement. J Hypertens 2019;37:1974–81. https://doi. org/10.1097/hjh.0000000000002148 68. Sheppard JP, Fletcher B, Gill P, Martin U, Roberts N, McManus RJ. Predictors of the home-clinic blood pressure difference: a systematic review and meta-analysis. Am J Hypertens 2016;29:614–25. https://doi.org/10.1093/ajh/hpv157 69. Franklin SS, Thijs L, Li Y, Hansen TW, Boggia J, Liu Y, et al. Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension 2013;61: 964–71. https://doi.org/10.1161/hypertensionaha.111.00289 70. Guirguis-Blake JM, Evans CV, Webber EM, Coppola EL, Perdue LA, Weyrich MS. Screening for hypertension in adults: updated evidence report and systematic review for the US preventive services task force. JAMA 2021;325:1657–69. https://doi.org/10. 1001/jama.2020.21669 71. Xu W, Goldberg SI, Shubina M, Turchin A. Optimal systolic blood pressure target, time to intensification, and time to follow-up in treatment of hypertension: population based retrospective cohort study. BMJ 2015;350:h158. https://doi.org/10.1136/bmj.h158 72. Antza C, Farmakis I, Doundoulakis I, Akrivos E, Stalikas N, Zafeiropoulos S, et al. Reproducibility of masked hypertension and office-based hypertension: a systematic review and meta-analysis. J Hypertens 2022;40:1053–9. https://doi.org/10.1097/hjh. 0000000000003111 73. Uhlig K, Patel K, Ip S, Kitsios GD, Balk EM. Self-measured blood pressure monitoring in the management of hypertension: a systematic review and meta-analysis. Ann Intern Med 2013;159:185–94. https://doi.org/10.7326/0003-4819-159-3-201308060-00008 74. Tucker KL, Sheppard JP, Stevens R, Bosworth HB, Bove A, Bray EP, et al. Self-monitoring of blood pressure in hypertension: a systematic review and individual patient data meta-analysis. PLoS Med 2017;14:e1002389. https://doi.org/10.1371/ journal.pmed.1002389 75. McManus RJ, Mant J, Franssen M, Nickless A, Schwartz C, Hodgkinson J, et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet 2018;391:949–59. https://doi.org/10.1016/s0140-6736(18)30309-x 76. McManus RJ, Little P, Stuart B, Morton K, Raftery J, Kelly J, et al. Home and Online Management and Evaluation of Blood Pressure (HOME BP) using a digital intervention in poorly controlled hypertension: randomised controlled trial. BMJ 2021;372:m4858. https://doi.org/10.1136/bmj.m4858 77. Li R, Liang N, Bu F, Hesketh T. The effectiveness of self-management of hypertension in adults using mobile health: systematic review and meta-analysis. JMIR Mhealth Uhealth 2020;8:e17776. https://doi.org/10.2196/17776 78. Acharya S, Neupane G, Seals A, Madhav KC, Giustini D, Sharma S, et al. Self-measured blood pressure-guided pharmacotherapy: a systematic review and meta-analysis of US-based telemedicine trials. Hypertension 2024;81:648–57. https://doi.org/10.1161/ hypertensionaha.123.22109 79. Monahan M, Jowett S, Nickless A, Franssen M, Grant S, Greenfield S, et al. Cost-effectiveness of telemonitoring and self-monitoring of blood pressure for antihypertensive titration in primary care (TASMINH4). Hypertension 2019;73:1231–9. https://doi.org/10.1161/hypertensionaha.118.12415 80. Wood S, Greenfield SM, Sayeed Haque M, Martin U, Gill PS, Mant J, et al. Influence of ethnicity on acceptability of method of blood pressure monitoring: a cross-sectional study in primary care. Br J Gen Pract 2016;66:e577–586. https://doi.org/10.3399/bjgp16X685717 81. Stergiou GS, Karpettas N, Destounis A, Tzamouranis D, Nasothimiou E, Kollias A, et al. Home blood pressure monitoring alone vs. combined clinic and ambulatory measurements in following treatment-induced changes in blood pressure and organ damage. Am J Hypertens 2014;27:184–92. https://doi.org/10.1093/ajh/hpt206 82. Staessen JA, Byttebier G, Buntinx F, Celis H, O’Brien ET, Fagard R. Antihypertensive treatment based on conventional or ambulatory blood pressure measurement. A randomized controlled trial. Ambulatory blood pressure monitoring and treatment of hypertension investigators. JAMA 1997;278:1065–72. https://doi.org/10.1001/jama. 1997.03550130039034 83. McEvoy JW, Leahy N, Parati G. The apples and oranges of blood pressure variability. Hypertension 2023;80:2556–8. https://doi.org/10.1161/hypertensionaha.123.21927 84. Ishikuro M, Obara T, Metoki H, Ohkubo T, Yamamoto M, Akutsu K, et al. Blood pressure measured in the clinic and at home during pregnancy among nulliparous and multiparous women: the BOSHI study. Am J Hypertens 2013;26:141–8. https://doi.org/10. 1093/ajh/hps002 85. Bello NA, Woolley JJ, Cleary KL, Falzon L, Alpert BS, Oparil S, et al. Accuracy of blood pressure measurement devices in pregnancy: a systematic review of validation studies. Hypertension 2018;71:326–35. https://doi.org/10.1161/hypertensionaha.117.10295 86. Tucker KL, Mort S, Yu LM, Campbell H, Rivero-Arias O, Wilson HM, et al. Effect of self-monitoring of blood pressure on diagnosis of hypertension during higher-risk pregnancy: the BUMP 1 randomized clinical trial. JAMA 2022;327:1656–65. https:// doi.org/10.1001/jama.2022.4712 87. Chappell LC, Tucker KL, Galal U, Yu L-M, Campbell H, Rivero-Arias O, et al. Effect of self-monitoring of blood pressure on blood pressure control in pregnant individuals with chronic or gestational hypertension: the BUMP 2 randomized clinical trial. JAMA 2022;327:1666–78. https://doi.org/10.1001/jama.2022.4726 88. Tita AT, Szychowski JM, Boggess K, Dugoff L, Sibai B, Lawrence K, et al. Treatment for mild chronic hypertension during pregnancy. N Engl J Med 2022;386:1781–92. https:// doi.org/10.1056/NEJMoa2201295 89. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018;39:3165–241. https://doi.org/10.1093/eurheartj/ehy340 90. Tikhonoff V, Kuznetsova T, Thijs L, Cauwenberghs N, Stolarz-Skrzypek K, Seidlerová J, et al. Ambulatory blood pressure and long-term risk for atrial fibrillation. Heart 2018; 104:1263–70. https://doi.org/10.1136/heartjnl-2017-312488 91. Lip GYH, Coca A, Kahan T, Boriani G, Manolis AS, Olsen MH, et al. Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). Europace 2017;19:891–911. https://doi.org/10.1093/europace/eux091 92. Šelmytė-Besusparė A, Barysienė J, Petrikonytė D, Aidietis A, Marinskis G, Laucevičius A. Auscultatory versus oscillometric blood pressure measurement in patients with atrial fibrillation and arterial hypertension. BMC Cardiovasc Disord 2017;17:87. https://doi. org/10.1186/s12872-017-0521-6 93. Omboni S, Ballatore T, Rizzi F, Tomassini F, Campolo L, Panzeri E, et al. 24-Hour ambulatory blood pressure telemonitoring in patients at risk of atrial fibrillation: results from the TEMPLAR project. Hypertens Res 2022;45:1486–95. https://doi.org/10. 1038/s41440-022-00932-1 94. Seccia TM, Letizia C, Muiesan ML, Lerco S, Cesari M, Bisogni V, et al. Atrial fibrillation as presenting sign of primary aldosteronism: results of the prospective appraisal on the prevalence of primary aldosteronism in hypertensive (PAPPHY) study. J Hypertens 2020;38:332–9. https://doi.org/10.1097/hjh.0000000000002250 95. McDonagh STJ, Mejzner N, Clark CE. Prevalence of postural hypotension in primary, community and institutional care: a systematic review and meta-analysis. BMC Fam Pract 2021;22:1. https://doi.org/10.1186/s12875-020-01313-8 96. Tran J, Hillebrand SL, Meskers CGM, Iseli RK, Maier AB. Prevalence of initial orthostatic hypotension in older adults: a systematic review and meta-analysis. Age Ageing 2021; 50:1520–8. https://doi.org/10.1093/ageing/afab090 97. Juraschek SP, Hu JR, Cluett JL, Ishak AM, Mita C, Lipsitz LA, et al. Orthostatic hypotension, hypertension treatment, and cardiovascular disease: an individual participant meta-analysis. JAMA 2023;330:1459–71. https://doi.org/10.1001/jama.2023.18497 Downloaded from academic.oup.com/eurheartj/article/45/38/3912/7741010 by guest on 07 October 2026